Japan's largest pharma and a Pennsylvania-based drug manufacturer have teamed up with four other companies to speed development and increase supply of a potential treatment for COVID-19, the disease caused by the novel coronavirus.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,